Current and future anti-VEGF agents for neovascular age-related macular degeneration

SM Kaiser, S Arepalli, JP Ehlers - Journal of Experimental …, 2021 - Taylor & Francis
Age-related macular degeneration (AMD) is the most common cause of legal blindness in
developed countries. Neovascular (ie, wet) AMD is currently managed with intravitreal …

Progression from intermediate to neovascular age‐related macular degeneration according to drusen subtypes: Bundang AMD cohort study report 3

KL Kim, K Joo, SJ Park, KH Park… - Acta Ophthalmologica, 2022 - Wiley Online Library
Purpose To investigate the ophthalmic risk factors related to neovascular change and the
subtype‐wise incidence of progression from intermediate to neovascular age‐related …

Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types

J Lee, S Choi, CS Lee, M Kim, SS Kim, HJ Koh… - American Journal of …, 2019 - Elsevier
Purpose To investigate the incidence of fellow eye (FE) neovascular age-related macular
degeneration (nAMD) in patients with unilateral nAMD according to FE drusen type. Design …